Filing Details

Accession Number:
0001209784-12-000038
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-06 19:43:42
Reporting Period:
2012-07-05
Filing Date:
2012-07-06
Accepted Time:
2012-07-06 19:43:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1116463 Orasure Technologies Inc OSUR Surgical & Medical Instruments & Apparatus (3841) 364370966
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1339299 R Stephen Lee 220 East First Street
Bethlehem PA 18015
Exec. Vp & Cso No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-07-05 10,600 $6.63 85,199 No 4 M Direct
Common Stock Acquisiton 2012-07-05 22,745 $5.19 107,944 No 4 M Direct
Common Stock Disposition 2012-07-05 62,021 $12.85 45,923 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified stock option Disposition 2012-07-05 10,600 $0.00 10,600 $6.63
Common Stock Non-qualified stock option Disposition 2012-07-05 22,745 $0.00 22,745 $5.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
31,800 2021-02-21 No 4 M Direct
22,745 2020-01-25 No 4 M Direct
Footnotes
  1. Sale pursuant to a predetermined sales plan, entered into on February 9, 2012, under Rule 10b5-1 of the Securities and Exchange Act of 1934.
  2. Nonqualified stock options granted on February 1, 2011 vesting and exercisable over a four year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.
  3. Nonqualified stock options granted on January 25, 2010 vesting and exercisable over a four year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.